【研报掘金丨国联民生:中国人寿产品转型效果较好,维持“买入”评级】国联民生证券研报指出,2025Q1中国人寿(601628.SH)NBV同比+4.8%;归母净利润为288.02亿元,同比+39.5%。截至2025Q1,公司代理人数为59.6万人,较2024年末减少1.9万人,公司的代理人队伍仍在出清。从产品结构来看,2025Q1在公司的首年期交保费中,浮动收益型业务的占比达51.72%,产品转型效果较好。全年来看,在公司持续优化产品结构、预定利率有望进一步下调、个险渠道执行“报行合一”等因素推动下,公司的价值率有望延续向好态势,进而能支撑NBV增长。鉴于公司负债端相对稳健以及资产端的弹性更大,维持“买入”评级。

金融界
May 06, 2025
国联民生证券研报指出,2025Q1中国人寿(601628.SH)NBV同比+4.8%;归母净利润为288.02亿元,同比+39.5%。截至2025Q1,公司代理人数为59.6万人,较2024年末减少1.9万人,公司的代理人队伍仍在出清。从产品结构来看,2025Q1在公司的首年期交保费中,浮动收益型业务的占比达51.72%,产品转型效果较好。全年来看,在公司持续优化产品结构、预定利率有望进一步下调、个险渠道执行“报行合一”等因素推动下,公司的价值率有望延续向好态势,进而能支撑NBV增长。鉴于公司负债端相对稳健以及资产端的弹性更大,维持“买入”评级。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10